Navigation Links
Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
Date:10/27/2009

BALTIMORE, Oct. 27 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company. The licensing agreement encompasses the development and commercialization of TAR-1, a single-chain antibody fragment in preclinical development that may have an advantage in treating cancer patients because of its high specificity and affinity to binding mutant p53 protein.

Under the terms of the agreement, Champions has obtained the worldwide rights to TAR-1 and is responsible for the further development of the compound. Champions will utilize its Biomerk Tumorgraft(TM) platform technology to evaluate the activity of TAR-1 and determine the best path forward for the compound in regards to indication, patient population and potential drug combinations. Ramot will receive an upfront payment and will be eligible to receive milestone payments and royalties if Champions chooses to continue the license terms, which will be determined based on results from testing TAR-1 in the predictive Tumorgraft platform.

Prof. Beka Solomon from Tel Aviv University identified that TAR-1 binds to and restores the wild-type active conformation of mutant p53 protein with a high degree of specificity, leading to in vivo inhibition of tumor growth. Given the frequency of mutant p53 in cancer, TAR-1 has the potential to target a wide range of human cancers.

"Licensing TAR-1 demonstrates the progression of our strategy to build our own Tumorgraft-driven pipeline of oncology drugs, which we expect to yield improved clinical development success rates," said Guy Malchi, Champions Biotechno
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
2. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
3. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
4. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
5. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
6. NASCAR Camping World Truck Series Driver Aric Almirola Waves the Yellow Flag at Warning Signs of Skin Cancer
7. Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement
8. Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China
9. AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
10. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
11. Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... MADRID , June 2, 2015 ... (Abstract   10503), vorgestellt auf dem Jahrestreffen ... PharmaMar teilt mit, dass Janssen ... der multizentrischen Phase-3-Studie SAR3007 bekannt gegeben ... Überleben (progression-free survival, PFS) mit Trabectedin (YONDELIS ...
(Date:6/1/2015)... LOS ANGELES , June 1, 2015 ... plaintiff,s law firm in the Snapchat and ... it filed a lawsuit against one of the most ... and its officers Retsina Meyer and Jeffrey Sabados ... co-founded Resilience with Defendant Meyer, a former colleague and fellow ...
(Date:6/1/2015)... The nuclear imaging market is estimated to ... of 12.08%. Nuclear medicine is the use of radioisotopes ... of Nuclear imaging used commonly are PET and SPECT. ... nuclear medicine applications like nuclear cardiology procedures. However, the ... shortage of molybdenum-99 isotope which is in turn will ...
Breaking Medicine Technology:PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 2PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 3PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 4PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 5PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 6Lee Tran & Liang LLP Files Co-Founder Lawsuit against Leading Biotech Start-up Resilience 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3
... LLC has launched a full line of non-prescription, topical ... relief of nerve pain caused by diabetes, post-shingles, chemotherapy, ... the only full line of skin care and pain ... developed from the ground up in oils, lotions and ...
... cites in its newly published " Medical Imaging ... medical imaging equipment exceeded $21 billion in ... Medical imaging can ... computed tomography (CT), positron emission tomography (PET), single ...
Cached Medicine Technology:Affordable Nerve Pain Treatment Now Available in the U.S. 2Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010 2Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010 3
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling ... their summer fashion cocktail dresses. The company carries more ... would be suitable for a wide variety of summer ... designs and make high quality trendy special occasion ... high quality satin, chiffon and cotton. Their products feature ...
(Date:6/2/2015)... 2015 First Choice Emergency Room ... in the United States, named Kenneth Alan Totz, D.O.as ... Road facility. , “We are pleased to announce ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director ... received his undergraduate degree from St. Edwards University in ...
(Date:6/2/2015)... Thermi, formerly ThermiAesthetics, a fast ... transitioned into its new company headquarters in Irving, ... continued rapid worldwide expansion and houses the corporate ... Thermi employees, including those of the warehousing, shipping ... one of the fastest growing aesthetic companies in ...
(Date:6/2/2015)... Join us for a new event in Westwood, ... Rhonda Martin , who overcame her brain aneurysm during the ... to raising awareness and funds for brain aneurysm research. ... that there will be one less case of someone suffering ... to join the 1st Anniversary Awareness Walk in Honor ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Miriam Wirski as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... present Miriam with this prestigious honor,” said NAPW President ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2
... a region of a human chromosome that is associated ... People with EoE frequently have difficulty eating or may ... further suggests that a suspected so-called master allergy gene ... rare but debilitating disorder. EoE is characterized ...
... between stress and death risk, researchers say , SUNDAY, March ... misery and death has helped researchers identify a gene variant ... U.S. research team focused on a gene called IL6, which ... to cardiovascular disease, neurodegeneration and some types of cancer. , ...
... ... , ... 2010 -- On Saturday, March 6 Yvonne’s Day Spa opened at Market Square at Potomac ... known in the Middle East and Asia as “doctor fish”, are minnow-like and toothless, and ...
... ... ... ... ...
... Louis, MO - Breast cancer patients with early stage disease ... benefit from radiation after mastectomy, because of the low present-day ... finding that could one day change the course of treatment ... at The University of Texas M. D. Anderson Cancer. ...
... ... Abelson says proposed curbs address an illusion instead of the real problem — doctors ... ... injury lawyer in Maryland and Washington, DC, says proposed limits on damage awards in ...
Cached Medicine News:Health News:NIAID media availability: Food allergy-related disorder linked to master allergy gene 2Health News:Gene Variant May Help Some Overcome Adversity 2Health News:Nibble Fish Arrive in Arlington Just in Time for Beautiful Toes for Oscar Night 2Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 2Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 3Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 4Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 5Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 2Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 3Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 2Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 3
...
...
...
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Medicine Products: